Related Experiment Video
Updated: Mar 30, 2026

08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
17.4K
Cardiac cachexia: hic et nunc: "hic et nunc" - here and now
International Journal of Cardiology
|November 8, 2015
Summary
Cardiac cachexia (CC), a complex heart failure complication, involves body wasting. Aerobic exercise training is the most effective strategy to combat skeletal muscle wasting in heart failure patients.
Area of Science:
- Cardiology
- Physiology
- Metabolic Disorders
Background:
- Cardiac cachexia (CC) is a complex clinical condition associated with advanced heart failure (HF).
- The definition and pathophysiology of CC remain challenging due to its multifactorial nature.
- Effective therapeutic strategies for CC are urgently needed.
Purpose of the Study:
- To explore the complex pathophysiology of cardiac cachexia.
- To identify potential biomarkers for early detection of body composition changes in CC.
- To review current and potential treatment strategies for CC.
Main Methods:
- Review of existing literature on cardiac cachexia and heart failure.
- Analysis of the complex biochemical pathways involved in CC.
- Evaluation of therapeutic interventions, including exercise training.
Main Results:
- CC pathophysiology is multifactorial, involving a complex biochemical network.
- Single biomarkers are insufficient to capture the full spectrum of CC.
- Aerobic exercise training is the most effective intervention for skeletal muscle wasting in HF patients.
Conclusions:
- Understanding CC pathophysiology is crucial for developing novel treatments.
- Biomarkers for early detection of body composition changes are highly desirable.
- Aerobic exercise training is a recommended and effective strategy to counteract muscle wasting in heart failure.
Related Concept Videos
Imbalances in Cardiac Output
3.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Cardiomyopathy II: Dilated Cardiomyopathy
757
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
757
Cardiomyopathy VI: Nursing Management
455
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
455
Pathophysiology of Heart Failure
4.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
708
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
708
Cardiomyopathy V: Interprofessional Care
637
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
637

